Premium
O1‐10‐02: TOXIC PGLU‐ABETA IS ENHANCED AND GLUTAMINYL CYCLASE (QC) UP‐REGULATED EARLY IN ALZHEIMER'S DISEASE (AD): INHIBITORS OF QC BLOCKING PGLU‐ABETA FORMATION ARE IN CLINICAL DEVELOPMENT
Author(s) -
Demuth HansUlrich,
Schilling Stephan,
Roßner Steffen,
Morawski Markus,
HartlageRübsamen Maike,
Lues Inge,
Glund Konrad
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.04.111
Subject(s) - in vivo , chemistry , neurotoxicity , downregulation and upregulation , neuroinflammation , microbiology and biotechnology , in vitro , context (archaeology) , biochemistry , neuroscience , biology , immunology , toxicity , inflammation , genetics , organic chemistry , gene , paleontology
O1-10-02 TOXIC PGLU-ABETA IS ENHANCED AND GLUTAMINYL CYCLASE (QC) UP-REGULATED EARLY IN ALZHEIMER’S DISEASE (AD): INHIBITORS OF QC BLOCKING PGLU-ABETA FORMATION ARE IN CLINICAL DEVELOPMENT Hans-Ulrich Demuth, Stephan Schilling, Steffen Roßner, Markus Morawski, Maike Hartlage-R€ubsamen, Inge Lues, Konrad Glund, Probiodrug AG, Halle (Saale), Germany; University of Leipzig, Leipzig, Germany. Contact e-mail: hans-ulrich.demuth@ probiodrug.de